Mark Offerhaus, CEO of the Dutch biotechnology company Micreos, presents Staphefekt against MRSA in Amsterdam on Nov.6, 2014
  • Time
  • Newsweek
  • The Times
  • Forbes

 

© 2010 - MICREOS